May: New Drug Approvals by the NMPA - April 2024

• Imported drugs:
• □　Baricitinib tablets (Brand name: OLUMIANT) marketed by Eli Lilly Nederland B.V.
• □　Cabotegravir injection marketed by ViiV Healthcare BV
• □　Cabotegravir sodium tablets marketed by ViiV Healthcare BV
• □　Faricimab injection (Brand name: VABYSMO) marketed by Roche Pharma (Schweiz) AG
• □　Human follitropin delta injection (Brand name: Rekovelle) marketed by Ferring Pharmaceuticals A/S
• □　Iptacopan hydrochloride capsules (Brand name: FABHALTA) marketed by Novartis Pharma Schweiz AG
• □　Mavacamten capsules (Brand name: CAMZYOS) marketed by Bristol-Myers Squibb Australia Pty Ltd.
• □　Nicorandil for injection marketed by Chugai Pharmaceutical Co.,Ltd.
• □　Perampanel tablets (Brand name: Fycompa) marketed by Eisai Europe Limited
• □　Rituximab subcutaneous injection marketed by Roche Pharma (Schweiz) AG
•  
•  
• Domestic drugs:
• □　Benmelstobart injection (TQB2450) (Brand name: 安得卫 (An De Wei)) marketed by CTTQ Pharma
• □　Bisoprolol fumarate and amlodipine besilate tablets marketed by Chengdu Shuode Pharmaceutical Co., Ltd.
• □　Chidamide tablets (Brand name: 爱谱沙 (Epidaza)) marketed by Chipscreen Biosciences
• □　Dexmedetomidine hydrochloride nasal spray (Brand name: 特美定 (Te Mei Ding)) marketed by Sichuan Purity Pharmaceutical Co., LTD.
• □　Entinostat tablets (Brand name: 景助达 (Jing Zhu Da)) marketed by EOC Pharma
• □　Human thyrotropin injection marketed by Suzhou Smartnuclide Biopharmaceutical Company
• □　Isavuconazonium sulfate for injection marketed by ASK Pharm
• □　Letermovir tablets marketed by CTTQ Pharma
• □　Linezolid oral suspension marketed by SSY Group Limited
• □　Metformin hydrochloride and empagliflozin tablets (III) marketed by Deyuan Pharm
• □　Oxcarbazepine oral suspension marketed by ApicHope Pharmaceutical Co., Ltd.
• □　Penpulimab injection (Brand name: 安尼可 (An Ni Ke)) marketed by CTTQ Pharma
• □　Recombinant human thrombopoietin injection (Brand name: 特比澳 (Te Bi Ao)) marketed by 3SBio Group
• □　Tislelizumab injection (Brand name: 百泽安 (Bai Ze An)) marketed by BeiGene, Ltd.
• □　Toripalimab injection (Brand name: 拓益 (Tuo Yi)) marketed by Junshi Biosciences
• □　Unecritinib fumarate capsules (Brand name: 安柏尼 (An Bo Ni)) marketed by CTTQ Pharma
• □　Vebreltinib enteric capsules (Brand name: 万比锐 (Wan Bi Rui)) marketed by Beijing Purun'ao Biotechnology Co., Ltd.
• (Source: BaiPharm)